+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cirrhosis"

From
Liver Diseases Treatment - Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment - Global Strategic Business Report

  • Report
  • March 2026
  • 194 Pages
  • Global
From
From
Human Liver Models - Global Strategic Business Report - Product Thumbnail Image

Human Liver Models - Global Strategic Business Report

  • Report
  • March 2026
  • 194 Pages
  • Global
From
Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • March 2026
  • 270 Pages
  • Global
From
From
Hepatic Encephalopathy Market Report 2026 - Product Thumbnail Image

Hepatic Encephalopathy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hepatorenal Syndrome Market Report 2026 - Product Thumbnail Image

Hepatorenal Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Overt Hepatic Encephalopathy Market - Product Thumbnail Image

Overt Hepatic Encephalopathy Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Loading Indicator

Cirrhosis is a condition in which the liver becomes scarred and unable to function properly. It is a common complication of chronic liver diseases such as hepatitis, alcohol abuse, and fatty liver disease. Symptoms of cirrhosis include jaundice, fatigue, abdominal pain, and fluid buildup in the abdomen. Treatment for cirrhosis includes lifestyle changes, medications, and in some cases, liver transplantation. The cirrhosis market is a subset of the hepatology market, which focuses on the diagnosis and treatment of liver diseases. The cirrhosis market is composed of pharmaceuticals, biologics, and medical devices used to treat cirrhosis. These products are used to reduce symptoms, slow the progression of the disease, and improve quality of life. Companies in the cirrhosis market include AbbVie, Gilead Sciences, Merck, Novartis, and Pfizer. Show Less Read more